At the same time as researchers seek out biomarkers to predict ketamine response, clinicians uncover on their own with a conundrum: Which patients should really start with IV ketamine, and which with Spravato? And just how do the two compare head to head in true reaction to treatment? Besides the https://hansc948bfj8.wikikali.com/user